Potatoes Don’t Increase Risk of Diabetes as Long as You Prepare Them Right, New Study Finds


A shopper is seen past a sign displaying the price per pound of russet potatoes at a supermarket in Montebello, Calif., on Aug. 23, 2022. (Frederic J. Brown/AFP via Getty Images)

A shopper is seen past a sign displaying the price per pound of russet potatoes at a supermarket in Montebello, Calif., on Aug. 23, 2022. (Frederic J. Brown/AFP via Getty Images)

0:004:28

Researchers in Australia have debunked previous findings that consuming potatoes is bad for your health and increases the risk of developing medical conditions such as Type 2 diabetes.

A team of researchers at Edith Cowan University (EDU) in Joondalup found that health issues associated with potatoes may actually be down to how they are prepared and what they are eaten with after analyzing a previous study on the issue.

The study was published in Diabetes Care, a peer-reviewed journal by the American Diabetes Association for health care providers, and examined the relationship between the intake of vegetables/ potatoes and the incidence of type 2 diabetes.

More than 54,000 people, aged between 50-64, reported their dietary intake for the long-term Danish Diet, Cancer and Health study via a dietary and lifestyle questionnaire over 12 months.

An analysis of that study, led by Dr. Nicola Bondonno from ECU’s Nutrition and Health Innovation Research Institute, found people who consumed the most vegetables were 21 percent less likely to develop type 2 diabetes than those who consumed the least amount of vegetables, after adjusting for lifestyle and demographic confounding variables.

insulin
A medical assistant holds an insulin pen administered to diabetes patients at a private clinic in New Delhi on Nov. 8, 2011. (Sajjad Hussain/AFP via Getty Images)

Vegetables Can Lower Diabetes Risk

Researchers also found while potatoes didn’t lower the risk of developing Type 2 diabetes, they also didn’t have any negative effects.

“In Denmark, people consume potatoes prepared in many different ways; in our study, we could distinguish between the different preparation methods,” Pratik Pokharel, a PhD candidate who worked on the study, said in a press release.

“When we separated boiled potatoes from mashed potatoes, fries, or crisps, boiled potatoes were no longer associated with a higher risk of diabetes: they had a null effect,” Pokharel added.

Pokharel noted that among the individuals who took part in the study, those who ate the most amount of potatoes also consumed them with additional items such as extra butter, red meat, and soft drinks, which are known to increase the risk of developing type 2 diabetes.

“When you account for that, boiled potatoes are no longer associated with diabetes,” Pokharel said. “It’s only fries and mashed potatoes, the latter likely because it is usually made with butter, cream, and the like.”

Researchers at EDU said the findings also suggest that vegetables could play a key role in reducing Type 2 diabetes; with individuals who took part in the study displaying a significantly lower risk of developing the condition when they ate plenty of leafy greens and other vegetables, specifically, spinach, lettuce, broccoli, and cauliflower.

someone boiling potatoes
(Pixel-Shot/Shutterstock)

Potatoes Can Aid Weight Loss, Study Finds

“The finding that vegetables lower diabetes risk is crucial for public health recommendations, and we shouldn’t ignore it,” Pokharel added.

More than 37 million Americans have diabetes, which works out to roughly 1 in 10 people, according to the Centers for Disease Control and Prevention (CDC). Of the more than 37 million living with the health condition—in which cells in the body do not respond normally to insulin—around 90-95 percent have been diagnosed with type 2 diabetes.

Typically, type 2 diabetes develops in people over the age of 45 but the CDC notes a rising number of diagnoses in children and teenagers.

Symptoms of diabetes include increased urination, particularly at night; increased thirst or hunger, tingling in the hands or feet, tiredness, dry skin, and blurred vision, among others. The medical condition is diagnosed through a simple blood test.

Experts recommend managing diabetes through a healthy diet and active lifestyle although insulin and other injectable medications are prescribed in some cases.

The latest study comes shortly after a separate study published in November in the peer-reviewed medical publication Journal of Medicinal Food found that potatoes do not increase the risk of developing type 2 diabetes risk and can actually aid in weight loss.

Eating potatoes in morning, vegetables in evening lowers mortality risk in diabetes


The time of day certain types of foods are eaten may affect risks for cardiovascular disease and all-cause mortality for adults with diabetes, according to study data published in The Journal of Clinical Endocrinology & Metabolism.

“We observed that eating potatoes in the morning, whole grains in the afternoon, greens and milk in the evening and less processed meat in the evening was associated with better long-term survival in people with diabetes,” Qingrao Song, MD, of the department of nutrition and food hygiene at the Harbin Medical University School of Public Health in China, said in a press release. “Nutritional guidelines and intervention strategies for diabetes should integrate the optimal consumption times for foods in the future.”

Risks for CVD mortality with diabetes reduced with dietary trends
Eating more potatoes in the morning, whole grains in the afternoon and dark vegetables in the evening can reduce the risk for CVD mortality in adults with diabetes. Data were derived from Jiang W, et al. J Clin Endocrinol Metab. 2022;doi:10.1210/clinem/dgac069.

Researchers analyzed data from 4,642 adults aged 18 years and older with diabetes who participated in the National Health and Nutrition Examination Survey from 2003 to 2014. Food intake data were collected during two nonconsecutive 24-hour dietary recalls, one taking place in person and the second occurring 3 to 10 days later by phone. Food consumption was analyzed in three time periods: morning, which consisted of breakfast plus a snack between breakfast and lunch; afternoon, including food eaten during lunch and a snack between lunch and dinner; and evening, including dinner plus any snack eaten after dinner. The cohort was divided into quantiles based on each participant’s intake of each food group. CVD and all-cause mortality data were obtained from the National Death Index through 2015. Researchers also built isocaloric models to analyze the RR of mortality when food intake was changed from one time period to another.

In the morning period, participants had a lower risk for CVD mortality if they were in the highest quantile for potatoes (HR = 0.46; 95% CI, 0.24-0.89), starchy vegetables (HR = 0.32; 95% CI, 0.15-0.72) and tomatoes (HR = 0.56; 95% CI, 0.33-0.97) compared with those in the lowest quantile for each of those groups. Adults in the highest quantiles for eating potatoes (HR = 0.71; 95% CI, 0.51-0.97), starchy vegetables (HR = 0.69; 95% CI, 0.49-0.95) and tomatoes (HR = 0.71; 95% CI, 0.53-0.94) during morning also had a decreased all-cause mortality risk compared with those in the lowest quantile.

In the afternoon, adults who consumed whole grains had a lower risk for CVD mortality compared with those who did not eat whole grains (HR = 0.67; 95% CI, 0.48-0.95). During the evening, people in the highest quantile for eating processed meat had a higher risk for CVD mortality compared with those in the lowest quantile (HR = 1.74; 95% CI, 1.07-2.82). Adults in the highest quantile for eating dark vegetables had a lower risk for CVD mortality compared with those in the lowest quantile (HR = 0.55; 95% CI, 0.35-0.87), and people in the highest quantile for drinking milk had a lower risk for CVD mortality (HR = 0.56; 95% CI, 0.36-0.88) and all-cause mortality (HR = 0.71; 95% CI, 0.54-0.92) compared with those in the lowest quantile.

In analysis of the isocaloric models, moving one-tenth of a serving of potatoes from afternoon or evening to morning decreased CVD mortality by 9%. Shifting one-tenth of a serving of starchy vegetables from afternoon to morning reduced CVD mortality by 14% and moving one-tenth of a serving from evening to morning lowered CVD mortality by 15%. CVD mortality declined 8% when one-tenth of a serving of dark vegetables was shifted from afternoon to evening. CVD mortality was reduced by 7% and all-cause mortality declined 3% when one-tenth of a serving of whole grain was moved from morning to the afternoon.

“The findings in our study have important implications,” the researchers wrote. “People with diabetes are under a disrupted biological rhythm of glucose metabolism, and accumulating evidence in recent years has indicated that food intake time is as important as quantity and quality for maintaining health. Therefore, nutritional therapy that considers consumption time will be a major component of diabetes treatment.”

Diet may influence the spread of a deadly type of breast cancer, study finds


Diet may influence the spread of a deadly type of breast cancer, study finds
Three-dimensional cell culture of breast cancer cells.

A single protein building block commonly found in food may hold a key to preventing the spread of an often-deadly type of breast cancer, according to a new multicenter study published today in the medical journal Nature.

Investigators found that by limiting an amino acid called asparagine in laboratory mice with triple-negative breast cancer, they could dramatically reduce the ability of the cancer to travel to distant sites in the body. Among other techniques, the team used dietary restrictions to limit asparagine.

Foods rich in asparagine include dairy, whey, beef, poultry, eggs, fish, seafood, asparagus, potatoes, legumes, nuts, seeds, soy and whole grains. Foods low in asparagine include most fruits and vegetables.

“Our study adds to a growing body of evidence that suggests diet can influence the course of the disease,” said Simon Knott, PhD, associate director of the Center for Bioinformatics and Functional Genomics at Cedars-Sinai and one of two first authors of the study. The research was conducted at more than a dozen institutions.

If further research confirms the findings in human cells, limiting the amount of asparagine cancer patients ingest could be a potential strategy to augment existing therapies and to prevent the spread of breast cancer, Knott added.

The researchers studied triple-negative breast cancer cells, which grow and spread faster than most other types of cancer cells. It is called triple negative because it lacks receptors for the hormones estrogen and progesterone and makes little of a protein called HER2. As a result, it resists common treatments—which target these factors and has a higher-than-average mortality rate.

Research from past studies found that most tumor cells remain in the primary breast site, but a subset of cells leaves the breast and enters the bloodstream. Those cells colonize in the lungs, brain and liver, where they proliferate. The study team wanted to understand the particular traits of the tumor cells circulating in the blood and in the sites where the cancer has spread.

The researchers discovered that the appearance of asparagine synthetase—the enzyme cells used to make asparagine—in a primary tumor was strongly associated with later cancer spread.

The researchers also found that metastasis was greatly limited by reducing asparagine synthetase, treatment with the chemotherapy drug L-asparaginase, or dietary restriction. When the lab mice were given food rich in asparagine, the cancer cells spread more rapidly.

“The study results are extremely suggestive that changes in diet might impact both how an individual responds to primary therapy and their chances of lethal disease spreading later in life,” said the study’s senior author, Gregory J. Hannon, PhD, professor of Cancer Molecular Biology and director, Cancer Research UK Cambridge Institute, University of Cambridge in England.

Investigators now are considering conducting an early-phase clinical trial in which healthy participants would consume a low-asparagine diet. If the diet results in decreased levels of asparagine, the next scientific step would involve a clinical trial with cancer patients. That trial likely would employ dietary restrictions as well as chemotherapy and immunotherapy, Knott said.

Studying the effects of asparagine also could alter treatments for other types of cancer, investigators say.

“This study may have implications not only for breast cancer, but for many metastatic cancers,” said Ravi Thadhani, MD, MPH, vice dean, Research and Graduate Research Education, at Cedars-Sinai.

MAGNESIUM: THE SAFE FIRST LINE OF DEFENSE FOR CLINICAL DEPRESSION


The science supporting the efficacy of magnesium for major depression and other psychiatric disorders, testing for magnesium deficiency, and which forms and dosages are most effective.

Depression, a life-threatening psychiatric disorder, lies at the confluence of biochemical, hormonal, immunological, and neurodegenerative variables, which intersect to generate the pro-inflammatory state with which depression is associated. A major public health issue, depression is estimated to become one of the top three contributors to the global burden of diseases within a few years. Not only does depression consume a sizable portion of health care expenditures, but it is considered to be an independent risk factor for metabolic, cardiovascular, and neuropsychiatric disorders (1).

Current treatments are predicated upon a misguided serotonin theory of depression, and are accompanied by a laundry list of deleterious side effects ranging from sexual dysfunction to homicidality (2, 3, 4). Antidepressant medications likewise significantly increase the risk of all-cause mortality, or death from any cause, as well as heart disease, leading researchers to deem this class of pharmaceuticals as harmful to the general population (5). This, in combination with data indicating that antidepressants are clinically equivalent to placebo, render them an unfavorable option (6), especially considering that they offer little in the way of resolving the root cause.

Magnesium: The Miracle Mineral

Rather than resorting to psychotropic drugs, it would be prudent to explore whether magnesium (Mg) supplementation improves depression, since this essential mineral is implicated in the pathophysiology of this disorder. Magnesium may be indeed branded as miraculous given its essentiality as a cofactor to over three hundred enzymatic reactions (7). It is second only to potassium in terms of the predominant intracellular cations, or ions residing in cells that harbor a positive charge (7).

 Magnesium is fundamentally involved in protein production, synthesis of nucleic acids, cell growth and division, and maintenance of the delicate electrolyte composition of our cells (7). It also imparts stability to the membranes of the energy factories of our cells called mitochondria (7). As articulated by researchers, “The physiological consequences of these biochemical activities include Mg’s central roles in the control of neuronal activity, cardiac excitability, neuromuscular transmission, muscular contraction, vasomotor tone, and blood pressure” (7).

The biological effects of magnesium are widespread. When deficient, magnesium is correlated with systemic inflammation. Not only does magnesium sufficiency promote cardiovascular health, relaxing the smooth muscles that comprise blood vessels and preventing high levels of vascular resistance that cause hypertension, but it also plays a role in musculoskeletal health and prevents sarcopenia, osteoporosis, and fractures (8). Magnesium is essential to regulation of sleep (9) and vitamin D metabolism (10) as well as neural plasticity and cognitive function.

However, food processing and industrial agriculture, including monoculture crop practices and the use of magnesium-devoid fertilizers, have led to soil erosion and depletion of magnesium content in our food (7). Magnesium is likewise removed from most drinking water supplies, rendering magnesium deficiency an inevitability (11). As such, our daily intake of magnesium has steadily declined from 500 milligrams (mg) per day to 175 mg per day (7). The nutrient-poor, energy-dense dietary patterns which have come to dominate the industrialized landscape are also insufficient in the fiber-rich fruits and vegetables which contain magnesium.

Animal Studies Propose a Role for Magnesium in Depression

Preliminary animal studies pointed to a role of magnesium in depression, as depletion of magnesium in the diet of mice lead to enhanced depression- and anxiety-related behavior such as increased immobility time in the forced swim test (12). In the forced swim test, a common assay for examining depression-like behavior in rodents, the animal is confined to a container filled with water and observed as it attempts to escape. The time in which the animal exhibits immobility is used as a barometer of despair, indicating that the animal has succumbed to a fate of drowning (1).

This model is confirmed by studies showing that administering substances with antidepressant properties such as Hypericum perforatum, also known as St. John’s Wort, can significantly decrease the time the animal spends without locomotor activity (12). In addition, the time the animal spends immobilized is influenced by many of the factors that are changed as a consequence of depression in humans, such as drug-withdrawal-induced anhedonia, impaired sleep, and altered food consumption (1).

Human Studies Confirm the Role of Magnesium in Depression

There is a paucity of research on the influence of specific micronutrients in depression and results are inconsistent, but several studies have revealed low serum magnesium in this mood disorder. It is well-documented, for example, that dietary magnesium deficiency in conjunction with stress can lead to neuropathologies and symptoms of psychiatric disorders. Researchers echo this sentiment, stating that, “Dietary deficiencies of magnesium, coupled with excess calcium and stress may cause many cases of other related symptoms including agitation, anxiety, irritability, confusion, asthenia, sleeplessness, headache, delirium, hallucinations and hyperexcitability” (11, p. 362).

The Hordaland Health study in Western Norway illustrated an inverse association between standardized energy-adjusted magnesium intake and depression scores, meaning that people who consumed less magnesium had higher rates of depression (13). When the serum and cerebrospinal fluid of acutely depressed patients diagnosed with major depressive disorder or bipolar patients in a depressive episode were compared to healthy controls, the calcium to magnesium ratio was found to be elevated in the former (14). Calcium and magnesium are minerals which antagonize one another and compete for absorption, since each of these minerals is a divalent cation (a positive ion with a valence of two). Suicidality, one of the primary manifestations of severe depression, is accompanied by low cerebrospinal fluid levels of magnesium despite normal calcium levels, lending credence to the role of magnesium in positive emotionality (15).

Magnesium Effective in Bipolar Disorder, Fibromyalgia, PMS, and Chronic Fatigue Syndrome

A formulation of magnesium aspartate hydrochloride known as Magnesiocard has been shown to invoke mood-stabilizing effects in patients with severe rapid cycling bipolar disorder in one open study label (16). In half of the patients treated, this magnesium preparation had results equivalent to lithium, the standard of care for this patient population, such that the researchers suggested: “The possibility that Magnesiocard could replace or improve the efficacy of lithium as a preventive treatment of manic-depressive illness merits further clinical investigation” (16, p. 171). When used as an adjunctive therapy in severe, therapy-resistant mania, magnesium sulphate infusions significantly reduced the use of lithium, benzodiazepines and neuroleptics, so much so that the researchers concluded that it “may be a useful supplementary therapy for the clinical management of severe manic agitation” (17, p. 239).

In another randomized trial of elderly patients with type 2 diabetes and magnesium deficiency, elemental magnesium administered at 450 mg per day was found to have equivalent efficacy to 50 mg of the antidepressant drug Imipramine in treating depressive symptoms (18). Magnesium citrate taken at 300 mg per day has likewise been shown to decrease depression and other symptoms in patients with fibromyalgia as indicated by significant decreases in the fibromyalgia impact questionnaire (FIQ) and Beck depression scores (19).

Data also indicate that supplementation with 360 mg of magnesium administered to women with premenstrual syndrome (PMS) three times a day in the second half of the cycle is effective for so-called negative affect and other premenstrual-related mood symptoms (20). Lastly, intramuscular magnesium sulphate administered every week for six weeks has been proven to be effective in improving emotional state and other parameters in chronic fatigue syndrome (CFS) (21).

Mechanism of Action for Antidepressant Effects of Magnesium

According to researchers, “Biological systems discussed to be involved in the pathophysiology of affective disorders and the action of mood stabilizing drugs are affected by Mg, such as the activity of the hypothalamus–pituitary–adrenocortical (HPA) system, corticotropin releasing factor (CRF)-, GABA- and glutamatergic (via NMDA receptors) neurotransmission and several transduction pathways including protein kinase C” (12). Not only that, but magnesium elicits similar effects on nocturnal hormonal secretion and sleep brain waves to lithium salts, which are used as a treatment modality for bipolar disorder, supporting the role of magnesium as a mood stabilizer (22).

Magnesium operates as an agonist, or a stimulatory molecule, for γ-aminobutyric acid (GABA) receptors (22). GABA is the main inhibitory neurotransmitter in the central nervous system. By binding to the GABA receptor and replicating the effects of GABA, magnesium may alleviate anxiety. Magnesium may also elicit its antidepressant effects by acting as an inorganic antagonist of N-methyl-d-aspartic acid (NMDA) receptor function (Poleszak et al., 2007). Receptor antagonists are ligands, or substances, which bind to a receptor but inhibit its activity rather than activating it. NMDA receptors, which occur on the surface of nerve cells, are activated in part by glutamate, one of the excitatory amino acids in the brain.

Researchers state that, “Dysfunction of NMDA receptors seems to play a crucial role in the neurobiology of disorders such as Parkinson’s diseaseAlzheimer’s diseaseepilepsy, ischemic stroke, anxiety and depression,” such that, “ligands interacting with different sites of NMDA receptor complex are widely investigated as potential agents for the treatment of a variety of neuropsychiatric disorders” (22). In fact, drug inhibitors at the NMDA receptor complex, such as ketamine, demonstrate antidepressant effects (23, 24), but also induce such severe side effects that their clinical utility is limited (31). Magnesium, on the other hand, may have a similar mechanism of action by interfering with NMDA receptor activation without the adverse consequences of drug-induced NMDA receptor blockade (25).

Recent Study Proves Efficacy of Oral Magnesium for Depression

A recent open-label, randomized, cross-over trial was conducted in outpatient primary care clinics on 126 adults diagnosed with depression (26). During the intervention, 248 mg of elemental magnesium chloride per day, obtained from four 500 mg tablets, was administered for six weeks and compared to six weeks of no treatment, and subjects were evaluated for changes in depressive symptoms (26).

Magnesium administration results in clinically significant improvements in scores on both the Patient Health Questionnaire-9 (PHQ-9), a validated measure of the severity of depression and response to treatment, as well as the Generalized Anxiety Disorders-7 (GAD-7), a sensitive self-reported screening tool for severity of anxiety disorders (26). Impressively, results appeared in as little as two weeks, representing the dramatic improvement that nutrient restoration can facilitate (26). Impressively, however, magnesium exerted anti-depressant effects regardless of baseline magnesium level. It also exhibited efficacy independent of the gender, age, or baseline severity of depression of subjects, as well as their use of antidepressant medications (26). The authors of the study conclude, “Magnesium is effective for mild-to-moderate depression in adults. It works quickly and is well tolerated without the need for close monitoring for toxicity” (26).

Populations At Risk for Magnesium Deficiency

Half of the population of the United States was found to consume less than the recommended amount of magnesium when estimated a decade ago (27). Not only is magnesium lost with certain medical conditions, but this mineral is excreted as a consequence of biological activities such as sweating, urinating, and defecating as well as excess production of stress hormones (7, 11). In addition, because low magnesium has been correlated with various disease states, increasing magnesium status may mitigate risk of these diseases.

For instance, researchers note that, “Low magnesium intakes and blood levels have been associated with type 2 diabetes, metabolic syndrome, elevated C-reactive protein, hypertension, atherosclerotic vascular disease, sudden cardiac death, osteoporosis, migraine headache, asthma, and colon cancer” (27, p. 153). In addition, magnesium deficiency at a cellular level “elicits calcium-activated inflammatory cascades independent of injury or pathogens” (27, p. 153). Low magnesium is associated with systemic inflammation, and inflammation is at the root of most chronic and degenerative diseases.

Testing for Magnesium and Food Sources of Magnesium

While the first inclination of some physicians may be to test magnesium levels for an objective parameter of deficiency, the widely used serum or plasma magnesium does not accurately reflect magnesium levels stored in other tissues (28, 29). In addition, both this hematological index of magnesium status, referred to as total magnesium, and the erythrocyte magnesium level, indicative of the levels of magnesium inside red blood cells, are not negatively affected until severe magnesium deprivation has occurred (7). Therefore, these testing methodologies are not accurate enough to catch preliminary or subclinical magnesium deficiency.

Good food sources of magnesium include pumpkin and squash seed kernels, Brazil nuts, almonds, cashews, peanuts, pine nuts, quinoa, spinach, Swiss chard, beet greens, potatoes, artichoke hearts, dates, bananas, coconut milk, prickly pear, black beans, lima beans, soybeans, and seafood sources including halibut, abalone, anchovy, caviar, conch, crab, oyster, scallop, snail, and pollock. However, it is important to note that magnesium can be leeched from vegetables when food is boiled, and that fiber in excess can decrease magnesium absorption by increasing gastrointestinal motility (7).

Most Bioavailable Forms of Magnesium

As elucidated by the researchers, “Over-the-counter magnesium can be offered as an alternative therapy to those patients hesitant to begin antidepressant treatment and is easily accessible without a prescription” (26). Because the soil is no longer enriched in magnesium, supplementation may be warranted. Organic salts of magnesium, including the acetate, ascorbate, aspartate, bicitrate, gluconate, and lactate forms are more soluble and biologically active over the magnesium mineral salts such as magnesium oxide, magnesium carbonate, magnesium chloride, and magnesium sulfate (7).

However, case studies have shown remarkably rapid recovery from major depression, in less than seven days, when magnesium glycinate and magnesium taurinate are administered at dosages of 125 to 300 mg with each meal and at bedtime (11). Magnesium threonate may also be explored as a therapeutic option, as it may have better penetrance of the blood brain barrier and restore neurological levels of magnesium. This form, which is delivered directly to the brain, may improve cerebral signaling pathways and synaptic connections between nerve cells as well as support learning and memory, although the studies have been conducted in animal models (30).

Researchers report that magnesium is usually effective for treating depression in general use, and that comorbid conditions occurring in these case studies, including “traumatic brain injury, headache, suicidal ideation, anxiety, irritability, insomnia, postpartum depression, cocaine, alcohol and tobacco abuse, hypersensitivity to calcium, short-term memory loss and IQ loss were also benefited” by magnesium supplementation (11, p. 362). Barring abnormal kidney function, the Institute of Medicine sets the upper tolerable limit for intake at 350 mg of elemental magnesium per day, but there are few adverse side effects documented unless consumed in inordinate doses (26).

Before changing your medication or nutraceutical regimen, always consult a functional or integrative medical doctor for contraindications. However, given the benign nature of magnesium supplementation and the ubiquity of magnesium insufficiency, depressedpatients should be offered this as a first line strategy alongside a holistic root-cause resolution approach to treating depression

Eating potatoes may cut stomach cancer risk.


White vegetables such as potatoes, onions and cauliflower in your diet may reduce the risk of developing stomach cancer, new research has claimed. DH Photo

Including large amounts of white vegetables such as potatoes, onions and cauliflower in your diet may reduce the risk of developing stomach cancer, new research has claimed.

However, beer, spirits, salt and preserved food increase the risk of the disease, researchers said.

Scientists at Zhejiang University in China found that people who ate large amounts of white vegetables were a third less likely to develop the cancer than those who largely avoided them.

Fruits and green-yellow vegetables such as cabbage, kale and celery also seemed to have a protective effect.

Vitamin C is thought to be the key nutrient, which acts as an antioxidant to cut down cellular stress in the stomach as well as fighting a bacterium responsible for causing gastric cancer.

The scientists analysed 76 best studies on diet and stomach cancer, which involved more than 6.3 million people and almost 33,000 deaths from the disease, ‘The Times’ reported.

They found that for every 100g of fruit a person ate each day – roughly equivalent to half an apple – there was 5 per cent reduced risk of stomach cancer.

Having 50mg of vitamin C daily, approximately two potatoes’ worth, brought the risk down by 8 per cent.

Every five grammes or teaspoon of salt consumed each day drove the risk up by 12 per cent. Alcohol in general had a negative effect, although wine did not seem to have any effect on stomach cancer, the researchers said.

Eating excess of pickled vegetables, liver and spinach also resulted in an increased risk of the disease.